Family Management’s Beyond Meat BYND Stock Holding History

Family Management’s Portfolio BYND Stock Details BYND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,696	Closed	-$267K	–	181
2021 Q2	$267K	Buy	+1,696	New	+$225K	0.07%	147
2020 Q3	–	Sell	-4,430	Closed	-$594K	–	132
2020 Q2	$594K	Hold	4,430	–	–	0.24%	78
2020 Q1	$295K	Buy	+4,430	New	+$430K	0.15%	96

Other funds holding BYND

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Family Management's BYND Position: Q3 2021 in Review

Family Management sold out of Beyond Meat (BYND) in Q3 2021, closing a stake of 1,696 shares — an estimated $267K sold.

Family Management first reported a position in BYND in Q1 2020 and held it in 3 quarters. The position peaked at $594K in Q2 2020. 421 funds tracked by Wall St. Rank hold BYND as of Q3 2021.

Family Management reported no remaining Beyond Meat position as of Q3 2021 after selling out during the quarter.
Family Management sold 1,696 Beyond Meat shares in Q3 2021, an estimated $267K.
Family Management first reported a position in Beyond Meat in Q1 2020 and held it in 3 quarters.
Family Management's Beyond Meat position peaked at $594K in Q2 2020.
421 funds tracked by Wall St. Rank held Beyond Meat as of Q3 2021.

Based on Family Management's 13F filing for Q3 2021, filed 15 Nov 2021.